Insights On Upstream Manufacturing
-
Rapid Production Of Assay Ready Cells For GPCR Drug Discovery
7/29/2025
Accelerate drug discovery by leveraging transiently transfected assay-ready cells. This method improves assay sensitivity and reduces variability for GPCRs.
-
Development Of A Landing-Pad CHO Cell Line For Mammalian Display
7/29/2025
A single-site "landing pad" CHO cell line simplifies the creation of mammalian display libraries, enabling consistent, single-copy integration of target sequences for biologic drug discovery.
-
Revolutionizing Cell Metabolism Monitoring
7/29/2025
Unlock real-time insights into cell health and productivity with continuous glucose and lactate monitoring. Discover how an innovative technology is transforming bioprocessing and research.
-
Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.
7/29/2025
In this episode of "Better Biopharma," Abalone Bio's CEO and co-founder, Richard Yu, Ph.D., explains how the company's functional antibody selection technology (FAST) platform differs from traditional affinity screening.
-
Key Requirements For Efficient Scale-Up Of Cell Therapy Products, Chapter Five
7/24/2025
Explore the final chapter of our webinar series, where we tackle the complexities of scaling shear-sensitive cell therapy manufacturing and discover practical solutions to streamline your process.
-
Key Requirements For Efficient Scale-Up Of Cell Therapy Products, Chapter Four
7/24/2025
Explore how a vertical wheel bioreactor enables efficient, linear scale-up of PSC cultures while maintaining quality, viability, and pluripotency for advanced cell therapy manufacturing.
-
Key Requirements For Efficient Scale-Up Of Cell Therapy Products, Chapter Three
7/24/2025
Discover how perfusion-based medium exchange and optimized oxygenation strategies overcome scale-up challenges in PSC cultures to ensure consistent growth, uniformity, and high-quality results.
-
Key Requirements For Efficient Scale-Up Of Cell Therapy Products, Chapter Two
7/24/2025
Explore how a vertical wheel bioreactor enables scalable iPSC expansion and differentiation, from 0.1L to 80L, with robust seed train optimization and consistent cell quality.
-
Key Requirements For Efficient Scale-Up Of Cell Therapy Products, Chapter One
7/24/2025
Discover advanced bioreactor systems and expert development services that can help you streamline your process and accelerate your path to clinical or commercial success.
-
Enhancing Protein Quality Through Optimized Galactosylation
7/23/2025
Advance your understanding of critical protein engineering. Explore expert strategies for optimizing complex molecular structures, paving the way for more effective and consistent biological products.